Back

Impact of beta-blockers on quality of life in patients with myocardial infarction without heart failure: a sub-study of the DANBLOCK-trial

23 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Secondary Prevention and Rehabilitation Treatment Delegates Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mrs Frida Rykind Eriksen

Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
Early post-discharge physical activity after myocardial infarction: safe and not linked to adverse outcomes
Mr R. Dijkman (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Impact of different clinic models on cardiometabolic risk optimisation and cardioprotective therapies in post myocardial infarction patients with type 2 diabetes
Ms S. Alasmary (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Beta-blocker therapy and angina pectoris after myocardial infarction: a BETAMI-DANBLOCK substudy
Doctor A. Kristensen (Frederiksberg, DK)
Abstract Slides

Access the full session

Session thumbnail
Young Investigator Award - Secondary Prevention and Rehabilitation
Video

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026
You may be interested in
thumbnail
Congress Session
Young Investigator Award - Secondary Prevention and Rehabilitation
thumbnail
Congress Session
HOT LINE 3
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources